CytomX Therapeutics, Inc. (32) | Intellectual Property (1)

Browse by Subcategory

License Agreements (1)

Recent Contracts

Amendment No.3 to Exclusive License Agreement effective as of April 2, 2019, by and between CytomX Therapeutics, Inc. and The Regents of the University of California (Filed With SEC on May 9, 2019)